← 返回首页
大洋洲 · 区域市场 · Stockhead

Orthocell partner receives US FDA clearance for marine-derived bone graft

来源:Stockhead · 澳大利亚 2 小时前

Perth-based Orthocell has finalised a strategic investment in Marine Biomedical in January 2026, increasing its equity interest to 12% for ... Read More The post Orthocell partner…

在 Stockhead 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (stockhead.com.au)

推荐阅读